Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 3:51 PM UTC
| NCT Number | NCT05519449 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE1 |
| Target Enrollment | 272 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Janux Therapeutics |
| Last Updated on CT.gov | August 13, 2026 (2 weeks ago) |
As of August 28, 2026: Clinical trial NCT05519449 is currently recruiting participants. This phase1 study for prostate cancer is actively seeking new participants at 33 locations across the United States. The study is sponsored by Janux Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05519449 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05519449 was last updated 2 weeks ago (August 13, 2026). HelloStudys verifies this status automatically.